Complete regression of metastatic malignant melanoma endoscopically after nivolumab administration
Saved in:
Main Authors: | Dae Gon Ryu, Cheol Woong Choi, Su Jin Kim, Dae Hwan Kang, Su Bum Park |
---|---|
Format: | article |
Language: | EN |
Published: |
The Korean Association of Internal Medicine
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/7dc520d21483412b82de2f0ffe3d1c67 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Autoimmune hemolytic anemia during long‐term administration of nivolumab for metastatic melanoma
by: Koji Nakajima, et al.
Published: (2021) -
Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
by: Alexander N Shoushtari, et al.
Published: (2021) -
Spontaneous Regression of Primary Melanoma and Multiple Melanocytic Nevi in a Patient With Metastatic Melanoma
by: Giovanni Paolino, et al.
Published: (2020) -
Nivolumab-induced new-onset seronegative rheumatoid arthritis in a patient with advanced metastatic melanoma: A case report and literature review
by: Ammar Haikal, et al.
Published: (2018) -
Novel Prognostic Score for recurrent or metastatic head and neck cancer patients treated with Nivolumab
by: Kiyoshi Minohara, et al.
Published: (2021)